Substance Use in Mild-COVID-19 Patients: A Retrospective Study

Frontiers in Public Health

Antonio Ventriglio¹  João M. Castaldelli-Maia²  Silvia S. Martins²  Megan E. Marziali²  Priscila D. Gonçalves²  Julio Torales³  João C. S. Bizario⁴  Beatriz Zaramella⁵  Tatiane Battagin⁵  Victoria Villela⁵  Lilian Bezerra de Queiroz⁵  Júlia Gallego⁵  Fabio E. Leal⁵  Flavia Ismael⁶ 

[1] Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy;Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States;Department of Psychiatry, School of Medical Sciences, National University of Asunción, Asunción, Paraguay;Faculdade de Medicina de Olinda, Olinda, Brazil;Universidade Municipal de São Caetano do Sul, São Caetano do Sul, Brazil;Universidade Municipal de São Caetano do Sul, São Caetano do Sul, Brazil;ABC Center for Mental Health Studies, Santo André, Brazil;

关键词: COVID-19;    alcohol;    analgesics;    cannabis;    tobacco;    benzodaizepine;   

DOI  :  10.3389/fpubh.2021.634396

来源: Frontiers

【 授权许可】

CC BY